Astellas Pharma Inc 2024 Integrated Report
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 102
The report describes FY2023 progress including the launch and expansion of major products, access to healthcare reaching 159.5 million patients in 103 countries, and approval of Astellas' updated science-based emissions targets. It also reports continued sustainability governance, renewable-energy initiatives and environmental performance across the Group.
Services
From bulk PDFs to structured indicators and machine-readable documents.